Amneal announces 10-year licensing and supply agreement with Jerome Stevens Pharmaceutical
Amneal Pharmaceuticals announced a 10-year license and supply agreement for Levothyroxine sodium tablets with Jerome Stevens Pharmaceuticals, a New York-based pharmaceutical manufacturer of prescription tablet and capsule formulations. The agreement is effective March 22, 2019. August 20, 2018